Gts Securities LLC Direxion Daily S&P Biotech Bea Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

A detailed history of Gts Securities LLC transactions in Direxion Daily S&P Biotech Bea stock. As of the latest transaction made, Gts Securities LLC holds 38,300 shares of LABD stock, worth $211,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,300
Previous 36,500 4.93%
Holding current value
$211,415
Previous $266,000 5.26%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$7.1 - $11.03 $325,748 - $506,056
-45,880 Reduced 49.32%
47,141 $345,000
Q1 2024

May 15, 2024
BUY
$5.9 - $10.3 $320,163 - $558,929
54,265 Added 140.02%
93,021 $678,000
Q4 2023

Feb 14, 2024
SELL
$9.2 - $29.48 $74,722 - $239,436
-8,122 Reduced 17.33%
38,756 $375,000
Q3 2023

Nov 15, 2023
BUY
$13.11 - $21.68 $257,126 - $425,209
19,613 Added 71.93%
46,878 $965,000
Q2 2023

Aug 15, 2023
BUY
$11.41 - $21.44 $311,093 - $584,561
27,265 New
27,265 $392 Million

Others Institutions Holding LABD

# of Institutions
27
Shares Held
2.68M
Call Options Held
973K
Put Options Held
248K
View Full List

About DIREXION DAILY S&P BIOTECH BEA

LABD Quotes by TradingView
  • Ticker LABD
  • Sector ETFs
  • Industry ETFs
More about LABD
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email